Affirm’s cash burn is an issue, according to independent equity research firm New Constructs...
Continue ReadingPre-sales for the latest iPhone may seem strong, but its lower-tiered models are not selling as expected...
Continue ReadingVertex Pharmaceuticals (NASDAQ: VRTX) is a monster stock because it's the undisputed master of the market for cystic fibrosis (CF) therapies. There are only about 25,000 CF patients in the Western world that are eligible but not currently enrolled in treatment with any of the company's six therapies for the condition. Vertex is advancing with commercial efforts to access that untapped market, not to mention chasing an even smaller population of around 5,000 patients for whom wholly new medicines are being developed...
Continue ReadingAn analysis of recent monetary policy decisions suggests the dollar is likely to remain strong in the foreseeable future. See what this means for tech stocks...
Continue ReadingAt a glance, this year’s Pros look unchanged from the previous model. But new chips improve noise-canceling, sound quality and findability when you misplace your case...
Continue ReadingRoku is one of many stocks that the market has been selling in an undiscerning fashion for nearly 18 months. Click to read why I think ROKU stock is a buy...
Continue ReadingSoftBank CEO Masayoshi Son said he is seeking a "strategic alliance" between chipmaker Arm, and South Korean tech conglomerate Samsung...
Continue ReadingApple is primed for a sell-off, not from its own doing but due to the slowdown in global economy. See why it might be a good time to rethink one's AAPL holding...
Continue ReadingOfcom, the U.K. media watchdog, is set to launch a study examining the role of Amazon, Microsoft and Google in the cloud services market...
Continue ReadingApple aims to be the first company to use an updated version of Taiwan Semiconductor Manufacturing Co’s latest chipmaking technology next year, with plans to adopt it for some of its iPhones and Mac computers, sources briefed on the matter told Nikkei Asia. The A17 mobile processor currently under development will be mass-produced using TSMC’s N3E chipmaking tech, expected to be available in the second half of next year, according to three people familiar with the matter. N3E is an upgraded version of TSMC’s current 3-nanometer production tech, which is only starting to go into use this year...
Continue Reading© 2026 Market News — All rights reserved